South and Central America Pharmacogenomics Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. South and Central America Pharmacogenomics Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. South and Central America Pharmacogenomics Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. South and Central America Pharmacogenomics Market Regional Analysis

6.2 South and Central America Pharmacogenomics Market Revenue 2019-2028 (US$ Million)

6.3 South and Central America Pharmacogenomics Market Forecast Analysis

7. South and Central America Pharmacogenomics Market Analysis – by Technology

7.1 PCR

7.1.1 Overview
7.1.2 PCR: South and Central America Pharmacogenomics Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.2 Sequencing

7.2.1 Overview
7.2.2 Sequencing: South and Central America Pharmacogenomics Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.3 Microarray

7.3.1 Overview
7.3.2 Microarray: South and Central America Pharmacogenomics Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.4 Gel Electrophoresis

7.4.1 Overview
7.4.2 Gel Electrophoresis: South and Central America Pharmacogenomics Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.5 Mass Spectrometry

7.5.1 Overview
7.5.2 Mass Spectrometry: South and Central America Pharmacogenomics Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. South and Central America Pharmacogenomics Market Analysis – by Application

8.1 Drug Discovery

8.1.1 Overview
8.1.2 Drug Discovery: South and Central America Pharmacogenomics Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.2 Oncology

8.2.1 Overview
8.2.2 Oncology: South and Central America Pharmacogenomics Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.3 Neurology and Psychiatry

8.3.1 Overview
8.3.2 Neurology and Psychiatry: South and Central America Pharmacogenomics Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.4 Pain Management

8.4.1 Overview
8.4.2 Pain Management: South and Central America Pharmacogenomics Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.5 Cardiovascular Diseases

8.5.1 Overview
8.5.2 Cardiovascular Diseases: South and Central America Pharmacogenomics Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. South and Central America Pharmacogenomics Market Analysis – by End User

9.1 Hospitals and Clinics

9.1.1 Overview
9.1.2 Hospitals and Clinics: South and Central America Pharmacogenomics Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.2 Biopharmaceutical Companies

9.2.1 Overview
9.2.2 Biopharmaceutical Companies: South and Central America Pharmacogenomics Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.3 CROs and CDMOs

9.3.1 Overview
9.3.2 CROs and CDMOs: South and Central America Pharmacogenomics Market – Revenue and Forecast, 2019-2028 (US$ Million)

10. South and Central America Pharmacogenomics Market – South and Central America Analysis

10.1 Overview

10.2 South and Central America

10.2.1 South and Central America Pharmacogenomics Market Breakdown, by Key Country, 2022 and 2028 (%)
10.2.1.1 South and Central America Pharmacogenomics Market – Revenue and Forecast Analysis – by Country
10.2.1.1 Brazil: South and Central America Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.1.1 Brazil: South and Central America Pharmacogenomics Market Breakdown, by Technology
10.2.1.1.2 Brazil: South and Central America Pharmacogenomics Market Breakdown, by Application
10.2.1.1.3 Brazil: South and Central America Pharmacogenomics Market Breakdown, by End User

10.2.1.2 Argentina: South and Central America Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.2.1 Argentina: South and Central America Pharmacogenomics Market Breakdown, by Technology
10.2.1.2.2 Argentina: South and Central America Pharmacogenomics Market Breakdown, by Application
10.2.1.2.3 Argentina: South and Central America Pharmacogenomics Market Breakdown, by End User

10.2.1.3 Rest of South and Central America : South and Central America Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.3.1 Rest of South and Central America : South and Central America Pharmacogenomics Market Breakdown, by Technology
10.2.1.3.2 Rest of South and Central America : South and Central America Pharmacogenomics Market Breakdown, by Application
10.2.1.3.3 Rest of South and Central America : South and Central America Pharmacogenomics Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Abbott

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 F. HOFFMANN-LA ROCHE LTD.

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Oxford Nanopore Technologies

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 THERMO FISHER SCIENTIFIC INC.

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Illumina, Inc.

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 QIAGEN

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Agilent Technologies, Inc.

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

South and Central America Pharmacogenomics Market